Lotus One Investment

Activity from announced rounds

Activity in this selectionOct 11, 2026 · Europe · Jan 1, 2026
Rounds participated in
2
Confirmed lead rounds
0
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$8.3M
2 disclosed · full round size, not this investor’s share

By stage

Pre-seed1
Undisclosed1

By primary sector

Biotech1
Healthtech1

By country

Sweden2

Rounds

2 in this selection
EnginZyme

EnginZyme develops cell-free biomanufacturing technology that uses immobilized enzymes to make chemicals and ingredients through scalable industrial processes.

SEK 75MEquity round
Participant
BRYM

Develops wearable EEG technology for cognitive performance improvement

€650KPre-Seed
Role not disclosed